nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliquidone—KCNJ8—adrenal cortex—polycystic ovary syndrome	0.0632	0.0913	CbGeAlD
Gliquidone—KCNJ8—endometrium—polycystic ovary syndrome	0.0564	0.0815	CbGeAlD
Gliquidone—KCNJ8—uterus—polycystic ovary syndrome	0.052	0.0751	CbGeAlD
Gliquidone—KCNJ8—pituitary gland—polycystic ovary syndrome	0.051	0.0738	CbGeAlD
Gliquidone—KCNJ8—adipose tissue—polycystic ovary syndrome	0.0508	0.0735	CbGeAlD
Gliquidone—KCNJ8—adrenal gland—polycystic ovary syndrome	0.0456	0.0659	CbGeAlD
Gliquidone—KCNJ8—female gonad—polycystic ovary syndrome	0.0425	0.0615	CbGeAlD
Gliquidone—ABCC8—endometrium—polycystic ovary syndrome	0.0423	0.0612	CbGeAlD
Gliquidone—KCNJ8—vagina—polycystic ovary syndrome	0.0423	0.0611	CbGeAlD
Gliquidone—KCNJ8—endocrine gland—polycystic ovary syndrome	0.0395	0.0572	CbGeAlD
Gliquidone—ABCC8—pituitary gland—polycystic ovary syndrome	0.0383	0.0554	CbGeAlD
Gliquidone—KCNJ11—adrenal gland—polycystic ovary syndrome	0.0372	0.0537	CbGeAlD
Gliquidone—ABCC8—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.0365	0.127	CbGpPWpGaD
Gliquidone—KCNJ11—female gonad—polycystic ovary syndrome	0.0346	0.0501	CbGeAlD
Gliquidone—ABCC8—adrenal gland—polycystic ovary syndrome	0.0342	0.0495	CbGeAlD
Gliquidone—KCNJ11—endocrine gland—polycystic ovary syndrome	0.0322	0.0466	CbGeAlD
Gliquidone—KCNJ11—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.0302	0.105	CbGpPWpGaD
Gliquidone—ABCC8—endocrine gland—polycystic ovary syndrome	0.0297	0.0429	CbGeAlD
Gliquidone—Glipizide—PPARG—polycystic ovary syndrome	0.0213	1	CrCbGaD
Gliquidone—KCNJ11—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.0153	0.0532	CbGpPWpGaD
Gliquidone—KCNJ11—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.0127	0.0443	CbGpPWpGaD
Gliquidone—KCNJ11—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.012	0.0419	CbGpPWpGaD
Gliquidone—ABCC8—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.0105	0.0367	CbGpPWpGaD
Gliquidone—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.0102	0.0356	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00856	0.0299	CbGpPWpGaD
Gliquidone—ABCC8—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.00836	0.0292	CbGpPWpGaD
Gliquidone—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.00811	0.0283	CbGpPWpGaD
Gliquidone—KCNJ11—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.00705	0.0246	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00544	0.019	CbGpPWpGaD
Gliquidone—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00526	0.0183	CbGpPWpGaD
Gliquidone—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.0051	0.0178	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00484	0.0169	CbGpPWpGaD
Gliquidone—KCNJ8—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00401	0.014	CbGpPWpGaD
Gliquidone—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.004	0.0139	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00391	0.0136	CbGpPWpGaD
Gliquidone—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00388	0.0135	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00382	0.0133	CbGpPWpGaD
Gliquidone—ABCC8—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00381	0.0133	CbGpPWpGaD
Gliquidone—KCNJ11—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.0037	0.0129	CbGpPWpGaD
Gliquidone—KCNJ8—Neuronal System—DLG4—polycystic ovary syndrome	0.00355	0.0124	CbGpPWpGaD
Gliquidone—ABCC8—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.003	0.0105	CbGpPWpGaD
Gliquidone—KCNJ11—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00291	0.0101	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00272	0.00948	CbGpPWpGaD
Gliquidone—ABCC8—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00255	0.0089	CbGpPWpGaD
Gliquidone—KCNJ11—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00248	0.00863	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00246	0.00857	CbGpPWpGaD
Gliquidone—ABCC8—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00201	0.007	CbGpPWpGaD
Gliquidone—ABCC8—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00196	0.00683	CbGpPWpGaD
Gliquidone—KCNJ11—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00195	0.00679	CbGpPWpGaD
Gliquidone—KCNJ11—Neuronal System—CAMK2D—polycystic ovary syndrome	0.0019	0.00662	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00188	0.00655	CbGpPWpGaD
Gliquidone—ABCC8—Neuronal System—DLG4—polycystic ovary syndrome	0.00173	0.00604	CbGpPWpGaD
Gliquidone—KCNJ11—Neuronal System—DLG4—polycystic ovary syndrome	0.00168	0.00585	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—NMNAT3—polycystic ovary syndrome	0.00159	0.00555	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—NMNAT3—polycystic ovary syndrome	0.00154	0.00538	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—LPCAT2—polycystic ovary syndrome	0.00146	0.00508	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—SUOX—polycystic ovary syndrome	0.00146	0.00508	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—LPCAT2—polycystic ovary syndrome	0.00141	0.00492	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—SUOX—polycystic ovary syndrome	0.00141	0.00492	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—ISYNA1—polycystic ovary syndrome	0.00135	0.00472	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—ISYNA1—polycystic ovary syndrome	0.00131	0.00458	CbGpPWpGaD
Gliquidone—KCNJ8—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.0013	0.00453	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—TEAD2—polycystic ovary syndrome	0.00115	0.00401	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—AKR1C2—polycystic ovary syndrome	0.00115	0.00401	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—TEAD2—polycystic ovary syndrome	0.00112	0.00389	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—AKR1C2—polycystic ovary syndrome	0.00112	0.00389	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00103	0.00358	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000965	0.00336	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000954	0.00333	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—PNPLA2—polycystic ovary syndrome	0.000936	0.00326	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000915	0.00319	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—SRD5A1—polycystic ovary syndrome	0.000887	0.00309	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—STAR—polycystic ovary syndrome	0.000873	0.00304	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000873	0.00304	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—STAR—polycystic ovary syndrome	0.000846	0.00295	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—HMMR—polycystic ovary syndrome	0.000778	0.00271	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—HMMR—polycystic ovary syndrome	0.000754	0.00263	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000742	0.00259	CbGpPWpGaD
Gliquidone—ABCC8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000732	0.00255	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—HSD3B1—polycystic ovary syndrome	0.00072	0.00251	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—LHB—polycystic ovary syndrome	0.000677	0.00236	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000661	0.00231	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—LHB—polycystic ovary syndrome	0.000656	0.00229	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—HSD3B2—polycystic ovary syndrome	0.000641	0.00224	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000641	0.00223	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	0.000621	0.00217	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—SULT2A1—polycystic ovary syndrome	0.00059	0.00206	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	0.000572	0.00199	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—RRM2—polycystic ovary syndrome	0.000571	0.00199	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	0.000554	0.00193	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—YAP1—polycystic ovary syndrome	0.00055	0.00192	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	0.000534	0.00186	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—NAMPT—polycystic ovary syndrome	0.000529	0.00184	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000522	0.00182	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	0.000513	0.00179	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	0.000506	0.00177	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000493	0.00172	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000486	0.00169	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	0.000478	0.00167	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	0.000471	0.00164	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—TH—polycystic ovary syndrome	0.00042	0.00146	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—SLC2A4—polycystic ovary syndrome	0.000409	0.00142	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—TH—polycystic ovary syndrome	0.000407	0.00142	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	0.000396	0.00138	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000384	0.00134	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	0.000373	0.0013	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—GNAS—polycystic ovary syndrome	0.000343	0.0012	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	0.000333	0.00116	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	0.000327	0.00114	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	0.000317	0.0011	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	0.00031	0.00108	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	0.0003	0.00105	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	0.000289	0.00101	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	0.00028	0.000976	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	0.000234	0.000816	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—POMC—polycystic ovary syndrome	0.000231	0.000805	CbGpPWpGaD
Gliquidone—ABCC8—Metabolism—INS—polycystic ovary syndrome	0.00023	0.0008	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	0.000227	0.000791	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	0.000224	0.000781	CbGpPWpGaD
Gliquidone—KCNJ11—Metabolism—INS—polycystic ovary syndrome	0.000223	0.000776	CbGpPWpGaD
